130 related articles for article (PubMed ID: 6568786)
1. Sensitivity of campylobacter isolates to clavulanate-potentiated amoxycillin.
Corbel MJ; Ibrahim ME; Gill KP
Vet Rec; 1984 Nov; 115(18):465. PubMed ID: 6568786
[No Abstract] [Full Text] [Related]
2. [Preliminary evaluation of the sensitivity of selected bacteria to amoxicillin and augmentin in comparison with other antibiotics used to date].
Ruczkowska J; Dolna I
Przegl Lek; 1984; 41(4):321-4. PubMed ID: 6565294
[No Abstract] [Full Text] [Related]
3. The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid.
Brown EM
J Antimicrob Chemother; 1984 Oct; 14(4):367-72. PubMed ID: 6501130
[TBL] [Abstract][Full Text] [Related]
4. Phenomenon of resistance to Augmentin associated with sensitivity to ampicillin: occurrence and explanation.
Brumfitt W; Hamilton-Miller JM; Dixson S; Gargan RA; Gooding A
J Clin Pathol; 1983 Jun; 36(6):670-3. PubMed ID: 6343436
[TBL] [Abstract][Full Text] [Related]
5. Clavulanate-potentiated amoxycillin: in vitro antibacterial activity and oral bioavailability in calves.
Soback S; Bor A; Kurtz B; Paz R; Ziv G
J Vet Pharmacol Ther; 1987 Jun; 10(2):105-13. PubMed ID: 3302313
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of enteric pathogens to amoxicillin and clavulanate-potentiated amoxicillin.
Mégraud F; Gavinet A
Chemioterapia; 1987 Jun; 6(2 Suppl):75-6. PubMed ID: 3334666
[No Abstract] [Full Text] [Related]
7. Divergent disk susceptibility of coagulase-negative staphylococci to penicillinase-resistant penicillins and augmentin (amoxycillin/clavulanic acid).
Traub WH
Chemotherapy; 1985; 31(2):119-23. PubMed ID: 3872778
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivities to amoxycillin/clavulanate and amoxycillin in general practice urinary infections.
Brumfitt W; Hamilton-Miller JM
Lancet; 1983 Sep; 2(8349):566. PubMed ID: 6136712
[No Abstract] [Full Text] [Related]
9. Clavulanate-potentiated amoxycillin: activity in vitro and bioavailability in the dog.
Bywater RJ; Palmer GH; Buswell JF; Stanton A
Vet Rec; 1985 Jan; 116(2):33-6. PubMed ID: 3871985
[TBL] [Abstract][Full Text] [Related]
10. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
Mashimo K
Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
[No Abstract] [Full Text] [Related]
11. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
Livermore DM; Seetulsingh P
J Antimicrob Chemother; 1991 Jun; 27(6):761-7. PubMed ID: 1669013
[TBL] [Abstract][Full Text] [Related]
12. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activity of augmentin against community and hospital-acquired gram-negative bacteria.
Glupczynski Y; McGillavry G; Yourassowsky E
Acta Clin Belg; 1988; 43(2):109-14. PubMed ID: 3400375
[No Abstract] [Full Text] [Related]
14. Comparative activity of BRL 25.000 with amoxycillin against resistant clinical isolates.
Van Landuyt HW; Pyckavet M; Lambert AM
J Antimicrob Chemother; 1981 Jan; 7(1):65-70. PubMed ID: 6907270
[No Abstract] [Full Text] [Related]
15. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
Bourgault AM; Lamothe F
J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
[TBL] [Abstract][Full Text] [Related]
16. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
[TBL] [Abstract][Full Text] [Related]
17. Microcalorimetric, turbidimetric, phase-contrast microscopic, and electron microscopic investigations of the actions of amoxicillin, clavulanic acid and augmentin on amoxicillin-sensitive and amoxicillin-resistant strains of Escherichia coli.
Semenitz E; Casey PA; Pfaller W; Gstraunthaler G
Chemotherapy; 1983; 29(3):192-207. PubMed ID: 6347546
[No Abstract] [Full Text] [Related]
18. In vitro susceptibility-resistance patterns of bacterial isolates from burn patients to augmentin and timentin.
Holder IA; Vanderpool L; Wesselman J
J Burn Care Rehabil; 1985; 6(4):331-4. PubMed ID: 3879938
[No Abstract] [Full Text] [Related]
19. Enterobacter resistant to amoxycillin/clavulanate.
Lancet; 1982 Oct; 2(8301):768-9. PubMed ID: 6125837
[No Abstract] [Full Text] [Related]
20. [Pharmaceutical preparation of BRL 25000].
Jpn J Antibiot; 1985 Feb; 38(2):538-41. PubMed ID: 3847526
[No Abstract] [Full Text] [Related]
[Next] [New Search]
